IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 8 holdings | $170.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kalvista Pharmaceuticals Inc(KALV)COM483497103$52.4K1,831,54830.7%
Avrobio IncCOM05455M100$42.6K1,930,70425.0%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$28.7K1,238,19816.9%
Sutro Biopharma IncCOM869367102$20.8K1,824,54212.2%
Transenterix IncCOM NEW89366M201$15.8K6,631,8329.3%
X4 Pharmaceuticals(ASNSUSD)COM98420X103$5.4K311,4903.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$2.5K628,2361.5%
Catabasis Pharmaceuticals in(CATBEUR)COM NEW14875P206$2.3K285,7651.3%